Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 334,517 | 350,736 | 306,681 | 271,566 | 180,426 |
| Marketable Securities | 59,451 | 29,743 | 118,402 | 208,564 | 267,601 |
| Receivables | 4,869 | 4,022 | 3,409 | 2,988 | 2,844 |
| TOTAL | $421,694 | $411,215 | $455,481 | $506,264 | $474,289 |
| Non-Current Assets | |||||
| PPE Net | 577 | 622 | 667 | 711 | 722 |
| Other Non-Current Assets | 2,162 | 2,498 | 3,948 | 4,287 | 2,922 |
| TOTAL | $2,739 | $3,120 | $4,615 | $4,998 | $3,644 |
| Total Assets | $424,433 | $414,335 | $460,096 | $511,262 | $477,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,553 | 25,282 | 17,079 | 12,006 | 8,992 |
| Accrued Expenses | 14,691 | 21,587 | 8,732 | 10,543 | 12,099 |
| TOTAL | $45,478 | $48,368 | $27,361 | $23,981 | $22,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,100 | 73,741 | 73,381 | 73,022 | N/A |
| Other Non-Current Liabilities | 966 | 2,000 | 2,241 | 2,293 | 2,869 |
| TOTAL | $74,474 | $74,776 | $74,791 | $74,700 | $2,079 |
| Total Liabilities | $119,952 | $123,144 | $102,152 | $98,681 | $24,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,728 | 64,231 | 64,231 | 64,204 | 64,012 |
| Common Shares | 7 | 6 | 6 | 6 | 6 |
| Retained earnings | -462,911 | -400,486 | -330,757 | -275,537 | -235,593 |
| Other shareholders' equity | 604 | 2,563 | 4,733 | 7,448 | 11,563 |
| TOTAL | $304,481 | $291,191 | $357,944 | $412,581 | $453,391 |
| Total Liabilities And Equity | $424,433 | $414,335 | $460,096 | $511,262 | $477,933 |